New Antithrombotic Drugs
Authors:
- 24 June 2009
- journal article
- review article
- Published by Wiley in Clinical Pharmacology & Therapeutics
- Vol. 86 (2) , 139-146
Abstract
Thrombosis, both venous and arterial, is a major cause of morbidity and mortality worldwide. Consequently, there is an ongoing search for new antithrombotic drugs, particularly novel antiplatelet agents and anticoagulants. A better understanding of the biochemical pathways involved in platelet activation and coagulation and of the links between these systems and the impact of thrombosis on inflammation has led to the identification of new targets for antithrombotic drugs. This paper focuses on these new targets and new antiplatelet drugs and anticoagulants and describes the major advances in the continuing search for more potent antithrombotic drugs that have limited effects on hemostasis.Keywords
This publication has 71 references indexed in Scilit:
- Pharmacology and Management of the Vitamin K AntagonistsChest, 2008
- Pharmacokinetics and Pharmacodynamics of the Direct Oral Thrombin Inhibitor Dabigatran in Healthy Elderly SubjectsClinical Pharmacokinetics, 2008
- Common polymorphisms of CYP2C19 and CYP2C9 affect the pharmacokinetic and pharmacodynamic response to clopidogrel but not prasugrelJournal of Thrombosis and Haemostasis, 2007
- Prasugrel versus Clopidogrel in Patients with Acute Coronary SyndromesNew England Journal of Medicine, 2007
- Factor Xa or thrombin: is factor Xa a better target?Journal of Thrombosis and Haemostasis, 2007
- Ximelagatran/melagatran against conventional anticoagulation: A meta-analysis based on 22,639 patientsInternational Journal of Cardiology, 2007
- A multiple dose study of prasugrel (CS‐747), a novel thienopyridine P2Y12 inhibitor, compared with clopidogrel in healthy humansBritish Journal of Clinical Pharmacology, 2006
- Hepatic Findings in Long-Term Clinical Trials of XimelagatranDrug Safety, 2005
- A Critical Role of Platelet Adhesion in the Initiation of Atherosclerotic Lesion FormationJournal of Experimental Medicine, 2002
- CYCLOOXYGENASES 1 AND 2Annual Review of Pharmacology and Toxicology, 1998